Marketing Authorization Approval In Japan For Tavalisse Tab. 100Mg And 150Mg, An Oral Spleen Tyrosine Kinase Inhibitor

Kissei Pharmaceutical

23/12/2022 06:06

Kissei Pharmaceutical Co Ltd  4547.T :
    * KISSEI PHARMACEUTICAL CO LTD - MARKETING AUTHORIZATION
APPROVAL
IN JAPAN FOR TAVALISSE TAB. 100MG AND 150MG, AN ORAL SPLEEN
TYROSINE KINASE INHIBITOR

Source text for Eikon:  ID:nTSxw8e2c7 
Further company coverage:  4547.T